These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21216887)

  • 1. Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.
    Tryc AB; Alwan G; Bokemeyer M; Goldbecker A; Hecker H; Haubitz M; Weissenborn K
    Nephrol Dial Transplant; 2011 Aug; 26(8):2635-41. PubMed ID: 21216887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible impact of dialysis modality on cognitive function in chronic dialysis patients.
    Radić J; Ljutić D; Radić M; Kovaĉić V; Sain M; Curković KD
    Neth J Med; 2010 Apr; 68(4):153-7. PubMed ID: 20421655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cognitive dysfunction in kidney disease.
    Nasser Mel T; Shawki S; El Shahawy Y; Sany D
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1208-14. PubMed ID: 23168850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
    Filley CM; Kozora E; Brown MS; Miller DE; West SG; Arciniegas DB; Grimm A; Zhang L
    Cogn Behav Neurol; 2009 Mar; 22(1):38-44. PubMed ID: 19372769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased resting energy expenditure in non-dialysed chronic kidney disease patients.
    Avesani CM; Draibe SA; Kamimura MA; Dalboni MA; Colugnati FA; Cuppari L
    Nephrol Dial Transplant; 2004 Dec; 19(12):3091-7. PubMed ID: 15507474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
    Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
    Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis.
    Blyth E; Favaloro EJ; Harris D; Kairaitis L
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):23-5. PubMed ID: 18180611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and 7-year mortality in dialysis patients.
    Griva K; Stygall J; Hankins M; Davenport A; Harrison M; Newman SP
    Am J Kidney Dis; 2010 Oct; 56(4):693-703. PubMed ID: 20800327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive profile of an adult sample with chronic kidney disease.
    Sánchez-Román S; Ostrosky-Solís F; Morales-Buenrostro LE; Nogués-Vizcaíno MG; Alberú J; McClintock SM
    J Int Neuropsychol Soc; 2011 Jan; 17(1):80-90. PubMed ID: 21062523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain dysfunction in uremia: a question of cortical hyperexcitability?
    Battaglia F; Quartarone A; Bagnato S; Rizzo V; Morgante F; Floccari F; Romeo A; Sant'Angelo A; Grasso G; Girlanda P; Buemi M
    Clin Neurophysiol; 2005 Jul; 116(7):1507-14. PubMed ID: 15908270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic alterations and cognitive dysfunction in children with chronic kidney disease using magnetic resonance spectroscopy and Wechsler intelligence scale.
    Youssef DM; Mohamed AH; Attia WMK; Mohammad FF; El Fatah NRA; El-Shal AS
    Nephrology (Carlton); 2018 Aug; 23(8):771-777. PubMed ID: 28621826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.